Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
about
Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.Autonomic dysfunction in Parkinson's disease: A prospective cohort study.Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease.
P2860
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@ast
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@en
type
label
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@ast
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@en
prefLabel
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@ast
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@en
P2093
P1433
P1476
Neurogenic orthostatic hypoten ...... tisation of treatment targets.
@en
P2093
Alberto J Espay
Aristide Merola
Mario Masellis
Peter A LeWitt
P304
P356
10.1016/S1474-4422(16)30079-5
P577
2016-08-01T00:00:00Z